(HealthDay) -- An activating mutation in GUCY2C, encoding guanylate cyclase C (GC-C), is thought to cause a novel familial diarrhea syndrome seen in a Norwegian family, according to a study published online March 21 in the New England Journal of Medicine.
Torunn Fiskerstrand, M.D., Ph.D., of the Haukeland University Hospital in Bergen, Norway, and colleagues describe the cause of a novel dominant disease in 32 members of a Norwegian family. Linkage analysis was used to identify a candidate region on chromosome 12, and GUCY2C was sequenced. Exome sequencing of the entire region was performed for three affected family members. Functional studies of mutant GC-C were carried out using HEK293T cells.
The researchers found that all affected family members had a heterozygous missense mutation in GUCY2C. In the candidate region, there were no other rare variants seen in exons of genes. There was a markedly increased production of cyclic guanosine monophosphate (cGMP) on exposure of the mutant receptor to its ligands.
"Increased GC-C signaling disturbs normal bowel function and appears to have a proinflammatory effect, either through increased chloride secretion or additional effects of elevated cellular cGMP," the authors write. "Further investigation of the relevance of genetic variants affecting the GC-C-cystic fibrosis transmembrane regulator pathway to conditions such as Crohn's disease is warranted."
Several authors disclosed financial ties to the pharmaceutical and biotechnology industries.
Explore further: Females are usually at higher risk than males in a maternal history of non-GCs
Full Text (subscription or payment may be required)